| 000 | 01509nam a2200409 c 4500 | ||
|---|---|---|---|
| 005 | 20250919214919.0 | ||
| 008 | 171212 2016 flua 000 0 eng | ||
| 020 |
_a9781498709552 _cRM344.02 |
||
| 039 | 9 |
_a201805251616 _bazriq _c201805231045 _dsalmah _y12-12-2017 _zsalmah |
|
| 040 |
_dUKM _erda |
||
| 090 |
_aQV771.4 _b.Y94b 2017 9HUKM |
||
| 100 | 1 |
_aYuan, Ying, _eauthor. |
|
| 245 | 1 | 0 |
_aBayesian designs for phase I-II clinical trials / _cYing Yuan, Hoang Q. Nguyen, Peter F. Thall. |
| 264 | 4 |
_aBoca Raton, Florida : _bCRC Press, _c[2016], ©2016. |
|
| 300 |
_axiv, 310 pages : _billustrations ; _c24 cm. |
||
| 336 |
_atext _2rdacontent |
||
| 337 |
_aunmediated _2rdamedia |
||
| 338 |
_avolume _2rdacarrier |
||
| 490 | 1 | _aChapman & Hall/CRC Biostatistics series | |
| 504 | _aIncludes bibliographical references (pages 283-300) and index. | ||
| 650 | 2 | _aClinical Trials, Phase I as Topic. | |
| 650 | 2 | _aClinical Trials, Phase II as Topic. | |
| 650 | 2 | _aStatistics as Topic. | |
| 650 | 2 | _aBayes Theorem. | |
| 650 | 2 | _aDose-Response Relationship, Drug. | |
| 700 | 1 |
_aNguyen, Hoang Q., _eauthor. |
|
| 700 | 1 |
_aThall, Peter F., _eauthor. |
|
| 830 | 0 | _aChapman & Hall/CRC Biostatistics series. | |
| 907 |
_a.b16545138 _b2020-03-30 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kQV771.4 .Y94b 2017 9HUKM |
||
| 914 | _avtls003629448 | ||
| 949 | _o100983208 | ||
| 990 | _aSalmah/azriq | ||
| 991 | _aJabatan Perubatan, PPUKM. | ||
| 998 |
_ah _b2017-12-12 _cm _da _feng _gflu _y0 _z.b16545138 |
||
| 999 |
_c691454 _d691454 |
||